» Articles » PMID: 6321640

Persistent Infection of Human Fibroblasts by Hepatitis A Virus

Overview
Journal J Gen Virol
Specialty Microbiology
Date 1984 Mar 1
PMID 6321640
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Infection of human embryo fibroblasts with hepatitis A virus (HAV), a picornavirus, leads to an inapparent, persistent infection; cultures can be passed serially with consistent recovery of the virus in the supernatant. All of the cells of a HAV carrier culture are infected and proliferate. Subcultivation under HAV-immune serum cannot achieve a cure or even a reduction in the number of infected cells in HAV carrier cultures. No interferon activity can be detected during HAV infection and persistence. Addition of exogenous interferon eliminates HAV infection in vitro. Persistence of HAV in vitro appears to contradict the clinical course of HAV infection in vivo. The system presented offers the possibility of evaluating the role of immunological injury of HAV-infected cells, an injury which may lead to damage of these cells and to elimination of HAV during an HAV infection in vivo.

Citing Articles

The Enterovirus Theory of Disease Etiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Critical Review.

ONeal A, Hanson M Front Med (Lausanne). 2021; 8:688486.

PMID: 34222292 PMC: 8253308. DOI: 10.3389/fmed.2021.688486.


Innate Immunity to Enteric Hepatitis Viruses.

Feng Z, Lemon S Cold Spring Harb Perspect Med. 2018; 9(3).

PMID: 29686040 PMC: 6396338. DOI: 10.1101/cshperspect.a033464.


Murine Models of Hepatitis A Virus Infection.

Hirai-Yuki A, Whitmire J, Joyce M, Tyrrell D, Lemon S Cold Spring Harb Perspect Med. 2018; 9(1).

PMID: 29661811 PMC: 6314078. DOI: 10.1101/cshperspect.a031674.


Hepatitis A virus-encoded miRNAs attenuate the accumulation of viral genomic RNAs in infected cells.

Shi J, Sun J, Wu M, Hu N, Hu Y Virus Genes. 2016; 52(3):317-24.

PMID: 26936379 DOI: 10.1007/s11262-016-1306-1.


Suppression of La antigen exerts potential antiviral effects against hepatitis A virus.

Jiang X, Kanda T, Wu S, Nakamoto S, Saito K, Shirasawa H PLoS One. 2014; 9(7):e101993.

PMID: 24999657 PMC: 4084951. DOI: 10.1371/journal.pone.0101993.